Larry Holmes at the age of 43 is lucky to be alive, but after battling AIDS for 14 years he is fearful that his luck is running out. Like thousands of other men who contracted the disease in the 1980s ...

Expert Rev Anti Infect Ther. 2010;8(12):1381-1402. The nucleoside reverse transcriptase inhibitors (NRTIs) were the first class of ARV drugs. NRTIs act by competitive inhibition of HIV's reverse ...

WASHINGTON (AP) -- Researchers may finally be on track to fight the AIDS virus by blocking a long-elusive target, an HIV enzyme called integrase. An experimental drug that inhibits the enzyme helped ...

Last week, the FDA linkurl:approved;http://www.reuters.com/article/health-SP/idUSN1221331120071015 Merck's raltegravir (Isentress), which interferes with viral replication at a different point, ...

Human immunodeficiency virus (HIV) is a quick learner. As fast as researchers get effective anti-viral drugs into clinical trials, the virus evolves, deploying potent resistance mutations that render ...

During replication and transmission of HIV (green), RNA is converted to DNA. With the CDC urging screening for all willing patients, providers will be testing and managing a growing number of ...

Human Immunodeficiency Virus Type 2 (HIV-2) remains a unique entity in the landscape of HIV research due to its distinct epidemiological and clinical characteristics. Predominantly confined to West ...